Morten Sogaard | Vice President And Head, Genome Sciences And Technologies, Worldwide R&D
Pfizer

Morten Sogaard, Vice President And Head, Genome Sciences And Technologies, Worldwide R&D, Pfizer

PFIZER. Responsibility for enterprise-wide scientific technology strategy, operations and investment reporting to the president of worldwide R&D, and a member of the worldwide R&D leadership team (WRDLT). As part of his responsibilities Morten oversees Pfizer’s global human genetics & computational biomedicine, companion diagnostic and biospecimen management organizations. He was previously responsible for strategic technology and oncology collaborations as part of External R&D Innovation, and co-led several Pfizer-wide strategy initiatives on Precision Medicine and scientific technologies.

INDUSTRY CAREER. Morten started his industry career at Pharmacia in Lund, Sweden, where he quickly advanced to section head, protein engineering and responsible for all aspects of next generation immuno-oncology antibody therapeutics overseeing a cross functional team of 50 across 3 sites in Italy and Sweden.  

In 1998, Morten moved to AstraZeneca where he headed up the Molecular Sciences Department in Mölndal, Sweden  leading about 100 scientists conducting genomics, proteomics, genetics and protein family research. He also headed up AZ’s global nuclear receptor program and was a member of the CVGI management team 

In 2004 Morten moved to Boehringer Ingelheim in Ridgefield, CT as VP and global head of enabling technology and a member of  BI’s global research leadership team. In this role he helped build a world-wide enabling technology function comprising global technology skill centers (Mab Lead discovery, high throughput protein expression, functional genomics, compound pool optimization, and fragment based screening), research informatics and an infrastructure for biologics research, and briefly served as Head of R&D Informatics.

EDUCATION. Morten received his Ph.D. degree in Biochemistry from the University of Copenhagen, Denmark. Thesis work done at the Carlsberg Laboratory, Dept. of Chemistry focused on heterologous protein expression and enzymology, and he subsequently did postdoctoral studies at Sloan Kettering Institute in New York with Nobel Laureate Jim Rothman  focusing on protein transport funded by NIH Fogarty and EMBO fellowships. 30+ publications including first author publications in PNAS, JBC, Cell, Gene, and Nature Biotechnology.

back to speakers

Contact us

To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174

alistair.wilmot@terrapinn.com


To speak:
Edward Glanville
+44 (0)207 092 1042

edward.glanville@terrapinn.com